Link between type 2 diabetes and alzheimers disease: from epidemiology to mechanism and treatment
Does GLP-1 treatment lead to muscle loss
Definitive Healthcares product portfolio includes all-payer claims data, reference and affiliations data, patient-level access and utilization insights, predictive analytics tools, and more
This synthetically manufactured peptide mimics growth hormone-releasing hormone (GHRH), stimulating the release of hGH, which effectively promotes muscle growth
However, the risk can increase if: You are also taking other medications that lower blood sugar, such as sulfonylureas or insulin
After stroke, NPCs have the ability to migrate to the lesion site, and chemokines and IGF-1 can promote NPCs proliferation, migration, and differentiation (101, 102)